Webpackaging logo

CSP Technologies, Inc. expanding Auburn, AL facility for increased manufacturing & warehousing space

  • Aptar CSP Technologies
North America, USA, US - The South, Eating, Drinking, Food, Dry Powders, Health, Medical, Diagnostics, Plastic, Contract Manufacturing, Processing, Blending, Contract Packaging, Packing, Kitting, Assembly, Supply Chain Services, Warehousing, Product Development Services

CSP Technologies, Inc. – a leader in designing and producing packaging solutions that ensure product protection, enhance brand recognition and improve consumer experiences – is expanding its Auburn, Alabama manufacturing and warehousing capacity by 110,000 square feet.  Construction of the new structure, located adjacent to the existing headquarters, is currently underway.

The expansion is necessary due to the recent growth in the areas of healthcare and food safety, and follows the commissioning of a new thermoforming line earlier in 2017.  The thermoforming operations will be the vehicle to deliver an upcoming portfolio of antimicrobial products for food safety.

During this same timeframe, the company added clean room manufacturing and high cavitation stack cube molding with in-mold process capabilities to increase manufacturing efficiency at its plant in Neiderbronn-les-Bains, France. Both the US and France operations will be ISO 13485:2016 certified for medical device manufacturing and assembly. The clean room installation also provides the necessary infrastructure as CSP prepares to manufacture dry powder inhalers and other medical devices in the near future. 

Over the last three years, CSP has greatly increased its global in-house design, engineering, material science and project management capabilities, providing a “one stop shop” from concept to commercialization. To its benefit, CSP Technologies has developed a built-in pipeline of excellent designers, engineers, and scientists by partnering with both Georgia Tech and Auburn Universities. This strong relationship has fostered internships into full-time opportunities at all disciplines.

These additional resources have resulted in a variety of new projects now nearing commercialization. The new infrastructure is anticipated to increase global production volume by as much as 25% in the areas of plastic processing – including injection molding, thermoforming, and product assembly and filling. 

“CSP Technologies is looking forward to expanding our global manufacturing and warehousing capacity with great pride, as it allows us to further broaden our portfolio of innovative products and packaging solutions, particularly to address recent growth in probiotics,” said John Belfance, CEO of CSP Technologies. “With six worldwide locations, and more than one billion products manufactured annually, we will have the capability to provide even more customers with the competitive edge CSP provides.”

See also

Aptar CSP Technologies’ Activ-Blister™ Solutions Now Available for Manufacturing in the EMEA Region

Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science solutions to ensure product protection, extend shelf life and improve patient experience, announces a new manufacturing site able to produce its Activ-Blister™ Solutions for oral slide dose drugs in Europe. The move is part of a key strategic effort to expand production of Activ-Blister™ technology globally.

Aptar CSP presents 'rethinking oral solid dose packaging' webinar

Aptar CSP Technologies – a leader in active packaging solutions that ensure product protection, enhance brand recognition and improve use experiences, and part of AptarGroup Inc – is presenting its Activ-Blister Solutions for the protection of moisture and oxygen-sensitive tablets and capsules, alongside FreeThink Technologies and its ASAPprime technology for accelerated shelf-life determination. The combination is a “right the first time” approach to stability challenges and blister package design that virtually eliminates protracted testing and costly reformulations.

CSP Technologies' focus for enhancing the shelf life for transdermal and oral solid dose drugs

Despite being two very different drug delivery platforms, oral solid doses and transdermal patches can face similar packaging headspace challenges that impact shelf life; besides moisture and oxygen ingress, exposure to certain conditions can lead to the formation of volatile organic compounds (VOCs) and other gases that, in turn, may interact with drug products and capsules, adversely impacting their stability.

  • Company News
  • English
  • Modified 05 Sep 2017
  • Hits 2358